Skip to content
Aperlena
Free alerts

Italy - Research services - Evidence reviews for the European Commission Initiatives on cancer screening and care

Closed Contract notice

Key facts

Closed
Estimated value
€5,500,000
Buyer
European Commission, DG JRC - Joint Research Centre
Where
Italy
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
73110000 Research services 73200000 Research and development consultancy services 85100000 Health services
Original language
English
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 month ago
Notice number
535174-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Published
  2. Deadline open for 59 days
  3. Awarded pending

Summary

Machine-generated summary

The European Commission's Joint Research Centre, Disease Prevention Unit, in Italy, is procuring research services to support European cancer guidelines and quality assurance schemes covering breast, cervical, colorectal, gastric, lung and prostate cancer. Lot 1 covers mapping exercises, systematic evidence reviews and Evidence to Decision frameworks for guideline recommendations. Lot 2 covers mapping exercises, evidence reviews and quality indicators worksheets for quality assurance schemes.

Description

The Disease Prevention Unit of the European Commission’s (EC) Joint Research Centre has been assigned with tasks in the field of cancer prevention and rare diseases that include the development of new European guidelines and quality assurance schemes for the six most prevalent cancer sites (breast, cervical, colorectal, gastric, lung and prostate cancer) representing over 50% of the cancer burden in the European Union. The purpose of this procurement procedure is to provide continuity for the collection, analysis and assessment of the underpinning evidence informing the EC initiatives, following a uniform methodological framework. The purpose of Lot 1 is to perform mapping exercises (e.g. background or scoping reviews, identification of existing guidelines) and evidence reviews, including systematic reviews, synthesis and critically appraisal of evidence, and definition of Evidence to Decision frameworks (EtDs) for the development and update of guideline recommendations, with emphasis, but not exclusively, on breast, colorectal, cervical and lung cancer. The purpose of Lot 2 is to perform mapping exercises (e.g. background or scoping reviews, identification of existing quality indicators) and evidence reviews, including systematic reviews, synthesis and critically appraisal of evidence, and definition of quality indicators worksheets and requirements for the development and update of quality indicators and requirements with emphasis, but not exclusively, on breast, colorectal, cervical and lung cancer. The Disease Prevention Unit of the European Commission’s (EC) Joint Research Centre has been assigned with tasks in the field of cancer prevention and rare diseases that include the development of new European guidelines and quality assurance schemes for the six most prevalent cancer sites (breast, cervical, colorectal, gastric, lung and prostate cancer) representing over 50% of the cancer burden in the European Union. The purpose of this procurement is to provide continuity for the collection, analysis and assessment of the underpinning evidence informing the EC initiatives, following a uniform methodological framework. The purpose of Lot 1 is to perform mapping exercises (e.g. background or scoping reviews, identification of existing guidelines) and evidence reviews, including systematic reviews, synthesis and critically appraisal of evidence, and definition of Evidence to Decision frameworks (EtDs) for the development and update of guideline recommendations, with emphasis, but not exclusively, on breast, colorectal, cervical and lung cancer.; The Disease Prevention Unit of the European Commission’s (EC) Joint Research Centre has been assigned with tasks in the field of cancer prevention and rare diseases that include the development of new European guidelines and quality assurance schemes for the six most prevalent cancer sites (breast, cervical, colorectal, gastric, lung and prostate cancer) representing over 50% of the cancer burden in the European Union. The purpose of this procurement procedure is to provide continuity for the collection, analysis and assessment of the underpinning evidence informing the EC initiatives, following a uniform methodological framework. The purpose of Lot 2 is to perform mapping exercises (e.g. background or scoping reviews, identification of existing quality indicators) and evidence reviews, including systematic reviews, synthesis and critically appraisal of evidence, and definition of quality indicators worksheets and requirements for the development and update of quality indicators and requirements with emphasis, but not exclusively, on breast, colorectal, cervical and lung cancer.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

8 open tenders right now

Recent awards

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Read before bidding
    • Submission deadline: Extended by 1 day: now September 30, 2026, 14:00
  2. Act now
    • Submission deadline: Brought forward by 1 day: now September 30, 2026, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.
  3. Act now
    • Estimated value: Set to €5,500,000
    • Submission deadline: Brought forward by 1 day: now September 30, 2026, 00:00
    • Estimated value: Set to €5,500,000

Follow this tender and we email you the moment it changes. Create account

Similar tenders

4

days left

TERBIUM

Italy Research & development FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI

€15,000

est. value

Market context

Avg. open tender · Research & development
€3,090,054
530 open across Europe right now 78% above sector average
Buyer track record on Aperlena
92 notices tracked · 21 awarded
€20,976,299 in awarded contracts

Never miss a tender like this

3 new notices in Research & development in Italy in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language